Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
EPS for Y-mAbs Therapeutics (YMAB)
EPS in 2023 (TTM): -$0.89
According to Y-mAbs Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.89. In 2022 the company made an earnings per share (EPS) of -$2.18 a decrease over its 2021 EPS that were of -$1.24.
EPS history for Y-mAbs Therapeutics from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.89 | -59.17% |
| 2022 | -$2.18 | 75.81% |
| 2021 | -$1.24 | -58.25% |
| 2020 | -$2.97 | 28.57% |
| 2019 | -$2.31 | 67.32% |
| 2018 | -$1.38 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 144.94% | 🇺🇸 USA |